item  management s discussion and analysis of financial condition and results of operations and note of the notes to consolidated financial statements for a more detailed discussion of dividend payment restrictions 
our policy is to retain earnings for the expansion and development of our business 
we do not anticipate paying cash dividends on our common stock in the foreseeable future 
see note of the notes to consolidated financial statements for information with respect to our stock based compensation plans 

table of contents stock performance graph the following performance graph compares the cumulative return of our shares of common stock over the preceding five year periods with that of the broad market nasdaq composite total returns index and the nasdaq health services index 
each index assumes invested at december  in our common stock and each index and also assumes dividend reinvestment 
logo december  company index transcend services  inc nasdaq composite total returns nasdaq health services index 
table of contents item selected financial data the following table sets forth selected consolidated financial data for the periods indicated  derived from our consolidated financial statements 
this selected financial data should be read in conjunction with the consolidated financial statements  related notes and other financial information included and incorporated by reference in this form k 
selected financial data in thousands  except per share data results of operations revenue operating income net income basic earnings per share weighted average shares outstanding diluted earnings per share diluted weighted average shares outstanding financial position at year end cash and cash equivalents investments total assets total long term debt total stockholders equity includes a million tax benefit from the reduction in deferred tax valuation allowances related to net operating loss carry forwards 

table of contents item management s discussion and analysis of financial condition and results of operations you should read the following discussion and analysis of our financial condition and results of operations in conjunction with our consolidated financial statements and the related notes included herein and or incorporated by reference into this annual report 
this discussion and analysis contains forward looking statements that involve risks  uncertainties  and assumptions 
our actual results may differ materially from those anticipated in these forward looking statements as a result of certain factors  including  but not limited to  those set forth under risk factors and elsewhere in this annual report or in documents incorporated by reference into this annual report 
overview we are the second largest medical transcription services company in the united states based on revenues 
we serve approximately hospital customers nationwide plus a number of clinics and physician s offices 
we estimate that our primary target market is approximately billion  comprised primarily of approximately  community based hospitals hospitals accessible by the general public in the united states 
our mission is to provide accurate and timely documentation of the patient medical provider encounter at a competitive price 
customer service is crucial to our success  and we have consistently been ranked among the top medical transcription service organizations in the industry 
our approximately  medical language specialists  including based in india  supplemented by our offshore partners  provide high quality medical documents and fast turnaround times  resulting in a high customer retention rate  which has averaged more than measured by revenues over the last four years 
we develop and utilize an array of technology solutions to support the transcription process  including robust voice capture systems  state of the art speech recognition technology  our proprietary transcription platforms and various customer specific systems 
we believe we are well positioned to benefit from the increasing adoption and use of electronic medical records  or emrs  because the data and narrative content we create comprise key portions of emrs 
hospitals have the flexibility of choosing between our two primary service delivery options 
customers with in house transcription platforms can partner with us to provide medical transcription services directly on their platform 
customers deciding to outsource this function can outsource the entire transcription process to us  in which case we provide our services using our proprietary transcription platforms 
our revenue is recurring in nature  which we believe results from our customers ongoing  mission critical need to document each doctor patient encounter and our consistently high service levels  resulting in high customer retention rates 
information about revenue  operating profit or loss and total assets is presented in 
